Guardian Investor Services’s Biogen BIIB Stock Holding History

Guardian Investor Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$684K	Sell	1,621 -9	-0.6%	-$3.55K	0.54%	42
2014 Q4	$553K	Sell	1,630 -52	-3%	-$16.8K	0.44%	51
2014 Q3	$556K	Sell	1,682 -77	-4%	-$25.4K	0.45%	48
2014 Q2	$555K	Sell	1,759 -63	-3%	-$19K	0.43%	52
2014 Q1	$557K	Sell	1,822 -80	-4%	-$25.4K	0.43%	53
2013 Q4	$532K	Hold	1,902	–	–	0.4%	56
2013 Q3	$458K	Sell	1,902 -18	-0.9%	-$4.03K	0.38%	60
2013 Q2	$413K	Buy	+1,920	New	+$410K	0.35%	62

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Guardian Investor Services's BIIB Position: Q1 2015 in Review

Guardian Investor Services reduced its Biogen (BIIB) stake by 0.55% in Q1 2015, selling an estimated $3.55K and leaving 1,621 shares worth $684K. The position accounts for 0.54% of the portfolio, ranked #42.

Guardian Investor Services first reported a position in BIIB in Q2 2013 and has held it in 8 quarters since. 967 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

Guardian Investor Services held 1,621 shares of Biogen worth $684K as of Q1 2015.
Guardian Investor Services sold 9 Biogen shares in Q1 2015, an estimated $3.55K.
Biogen made up 0.54% of Guardian Investor Services's portfolio in Q1 2015, its #42 holding.
Guardian Investor Services first reported a position in Biogen in Q2 2013 and has held it in 8 quarters since.
967 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on Guardian Investor Services's 13F filing for Q1 2015, filed 5 May 2015.